Artykuły w czasopismach na temat „Inhibition covalente”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Inhibition covalente”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Aljoundi, Aimen, Ahmed El Rashedy, Patrick Appiah-Kubi i Mahmoud E. S. Soliman. "Coupling of HSP72 α-Helix Subdomains by the Unexpected Irreversible Targeting of Lysine-56 over Cysteine-17; Coevolution of Covalent Bonding". Molecules 25, nr 18 (16.09.2020): 4239. http://dx.doi.org/10.3390/molecules25184239.
Pełny tekst źródłaLiu, S. Q., i P. A. Knauf. "Lys-430, site of irreversible inhibition of band 3 Cl- flux by eosin-5-maleimide, is not at the transport site". American Journal of Physiology-Cell Physiology 264, nr 5 (1.05.1993): C1155—C1164. http://dx.doi.org/10.1152/ajpcell.1993.264.5.c1155.
Pełny tekst źródłaYang, Jianhong, Yong Li, Wei Yan, Weimin Li, Qiang Qiu, Haoyu Ye i Lijuan Chen. "Covalent modification of Cys-239 in β-tubulin by small molecules as a strategy to promote tubulin heterodimer degradation". Journal of Biological Chemistry 294, nr 20 (2.04.2019): 8161–70. http://dx.doi.org/10.1074/jbc.ra118.006325.
Pełny tekst źródłaMaksimenko, A. V., i R. Sh Beabealashvili. "Theoretical Grounding and Formation of Experimental Approaches to Hyaluronidase Structure Consolidation due to Its Computational Interactions with Shortchain Glycosaminoglycan Ligands". Биоорганическая химия 49, nr 4 (1.07.2023): 369–83. http://dx.doi.org/10.31857/s0132342323020161.
Pełny tekst źródłaBhatia, Sumeena, Steven C. Almo, Stanley G. Nathenson i Richard J. Hodes. "Dynamic equilibrium of B7-1 dimers and monomers is important for regulation of TCR/CD28 – mediated T cell activation (33.28)". Journal of Immunology 182, nr 1_Supplement (1.04.2009): 33.28. http://dx.doi.org/10.4049/jimmunol.182.supp.33.28.
Pełny tekst źródłaKuznetsova, Anastasiya, Philipp Klein i Till Opatz. "Halogenated 2,1,3-benzoxadiazoles as Potential Fluorescent Warheads for Covalent Protease Inhibitors". Proceedings 9, nr 1 (14.11.2018): 54. http://dx.doi.org/10.3390/ecsoc-22-05670.
Pełny tekst źródłaHognon, Cécilia, Marco Marazzi i Cristina García-Iriepa. "Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease". International Journal of Molecular Sciences 23, nr 10 (23.05.2022): 5855. http://dx.doi.org/10.3390/ijms23105855.
Pełny tekst źródłaBisconte, Angelina, Ronald Hill, Michael Bradshaw, Erik Verner, David Finkle, Ken Brameld, Jens Funk, David Goldstein i Phil Nunn. "Efficacy in collagen induced arthritis models with a selective, reversible covalent Bruton’s tyrosine kinase inhibitor PRN473 is driven by durable target occupancy rather than extended plasma exposure (THER5P.904)". Journal of Immunology 194, nr 1_Supplement (1.05.2015): 139.6. http://dx.doi.org/10.4049/jimmunol.194.supp.139.6.
Pełny tekst źródłaBeck, Philipp, Christian Dubiella i Michael Groll. "Covalent and non-covalent reversible proteasome inhibition". Biological Chemistry 393, nr 10 (1.10.2012): 1101–20. http://dx.doi.org/10.1515/hsz-2012-0212.
Pełny tekst źródłaPiestrzeniewicz, Mariola K., Dorota Wilmańska, Janusz Szemraj, Kazimierz Studzian i Marek Gniazdowski. "Interactions of Novel Morpholine and Hexamethylene Derivatives of Anthracycline Antibiotics with DNA". Zeitschrift für Naturforschung C 59, nr 9-10 (1.10.2004): 739–48. http://dx.doi.org/10.1515/znc-2004-9-1020.
Pełny tekst źródłaMüller, Patrick, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten i in. "Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study". International Journal of Molecular Sciences 24, nr 8 (13.04.2023): 7226. http://dx.doi.org/10.3390/ijms24087226.
Pełny tekst źródłaGerling, Katharina, Sabrina Ölschläger, Meltem Avci-Adali, Bernd Neumann, Ernst Schweizer, Christian Schlensak, Hans-Peter Wendel i Sandra Stoppelkamp. "A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood". Biomolecules 10, nr 7 (13.07.2020): 1042. http://dx.doi.org/10.3390/biom10071042.
Pełny tekst źródłaStellmacher, Lena, Tatyana Sandalova, Sarah Schneider, Gunter Schneider, Georg A. Sprenger i Anne K. Samland. "Novel mode of inhibition byD-tagatose 6-phosphate through a Heyns rearrangement in the active site of transaldolase B variants". Acta Crystallographica Section D Structural Biology 72, nr 4 (24.03.2016): 467–76. http://dx.doi.org/10.1107/s2059798316001170.
Pełny tekst źródłaBetori, Rick C., Yue Liu, Rama K. Mishra, Scott B. Cohen, Stephen J. Kron i Karl A. Scheidt. "Targeted Covalent Inhibition of Telomerase". ACS Chemical Biology 15, nr 3 (4.02.2020): 706–17. http://dx.doi.org/10.1021/acschembio.9b00945.
Pełny tekst źródłaGhosh, Avick Kumar, Indranil Samanta, Anushree Mondal i Wenshe Ray Liu. "Covalent Inhibition in Drug Discovery". ChemMedChem 14, nr 9 (26.03.2019): 889–906. http://dx.doi.org/10.1002/cmdc.201900107.
Pełny tekst źródłaRao, AK, i MA Kowalska. "ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'- p-fluorosulfonylbenzoyladenosine is a weak platelet agonist". Blood 70, nr 3 (1.09.1987): 751–56. http://dx.doi.org/10.1182/blood.v70.3.751.751.
Pełny tekst źródłaRao, AK, i MA Kowalska. "ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5'- p-fluorosulfonylbenzoyladenosine is a weak platelet agonist". Blood 70, nr 3 (1.09.1987): 751–56. http://dx.doi.org/10.1182/blood.v70.3.751.bloodjournal703751.
Pełny tekst źródłaBjij, Imane, Fisayo A. Olotu, Clement Agoni, Emmanuel Adeniji, Shama Khan, Ahmed El Rashedy, Driss Cherqaoui i Mahmoud E. S. Soliman. "Covalent Inhibition in Drug Discovery: Filling the Void in Literature". Current Topics in Medicinal Chemistry 18, nr 13 (4.10.2018): 1135–45. http://dx.doi.org/10.2174/1568026618666180731161438.
Pełny tekst źródłaStrelow, John M. "A Perspective on the Kinetics of Covalent and Irreversible Inhibition". SLAS DISCOVERY: Advancing the Science of Drug Discovery 22, nr 1 (5.10.2016): 3–20. http://dx.doi.org/10.1177/1087057116671509.
Pełny tekst źródłaKilbourn, R., i G. Lopez-Berestein. "Protease inhibitors block the macrophage-mediated inhibition of tumor cell mitochondrial respiration." Journal of Immunology 144, nr 3 (1.02.1990): 1042–45. http://dx.doi.org/10.4049/jimmunol.144.3.1042.
Pełny tekst źródłaColman, RW, WR Figures, LM Scearce, AM Strimpler, FX Zhou i AK Rao. "Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides". Blood 68, nr 2 (1.08.1986): 565–70. http://dx.doi.org/10.1182/blood.v68.2.565.565.
Pełny tekst źródłaColman, RW, WR Figures, LM Scearce, AM Strimpler, FX Zhou i AK Rao. "Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides". Blood 68, nr 2 (1.08.1986): 565–70. http://dx.doi.org/10.1182/blood.v68.2.565.bloodjournal682565.
Pełny tekst źródłaTian, Yafeng, Mi Zhang, Panpan Heng, Hua Hou i Baoshan Wang. "Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases". International Journal of Molecular Sciences 24, nr 20 (16.10.2023): 15223. http://dx.doi.org/10.3390/ijms242015223.
Pełny tekst źródłaZhou, X. Edward, Kelly Suino-Powell, Chad R. Schultz, Bilal Aleiwi, Joseph S. Brunzelle, Jared Lamp, Irving E. Vega, Edmund Ellsworth, André S. Bachmann i Karsten Melcher. "Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane". Biochemical Journal 478, nr 23 (6.12.2021): 4137–49. http://dx.doi.org/10.1042/bcj20210647.
Pełny tekst źródłaKinoshita, T., A. W. Dodds, S. K. A. Law i K. Inoue. "The low C5 convertase activity of the C4A6 allotype of human complement component C4". Biochemical Journal 261, nr 3 (1.08.1989): 743–48. http://dx.doi.org/10.1042/bj2610743.
Pełny tekst źródłaStevic, Ivan, Howard H. W. Chan, Ankush Chander, Leslie R. Berry i Anthony K. C. Chan. "Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets". Thrombosis and Haemostasis 109, nr 06 (2013): 1016–24. http://dx.doi.org/10.1160/th12-10-0766.
Pełny tekst źródłaSim, E., A. W. Dodds i A. Goldin. "Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent". Biochemical Journal 259, nr 2 (15.04.1989): 415–19. http://dx.doi.org/10.1042/bj2590415.
Pełny tekst źródłaLu, Jia-Hui, Zhen Li, Jia-Hui Chen, Shu-Liang Li, Jie-Hao He, Song Gu, Bo-Wen Liu, Li Chen i Yu-Zhong Wang. "Adaptable Phosphate Networks towards Robust, Reprocessable, Weldable, and Alertable-Yet-Extinguishable Epoxy Vitrimer". Research 2022 (6.10.2022): 1–12. http://dx.doi.org/10.34133/2022/9846940.
Pełny tekst źródłaRuddraraju, Kasi Viswanatharaju, i Zhong-Yin Zhang. "Covalent inhibition of protein tyrosine phosphatases". Molecular BioSystems 13, nr 7 (2017): 1257–79. http://dx.doi.org/10.1039/c7mb00151g.
Pełny tekst źródłaZhao, Yuguang, Fredrik Svensson, David Steadman, Sarah Frew, Amy Monaghan, Magda Bictash, Tiago Moreira i in. "Structural Insights into Notum Covalent Inhibition". Journal of Medicinal Chemistry 64, nr 15 (22.07.2021): 11354–63. http://dx.doi.org/10.1021/acs.jmedchem.1c00701.
Pełny tekst źródłaWestover, Kenneth D., Pasi A. Jänne i Nathanael S. Gray. "Progress on Covalent Inhibition of KRASG12C". Cancer Discovery 6, nr 3 (marzec 2016): 233–34. http://dx.doi.org/10.1158/2159-8290.cd-16-0092.
Pełny tekst źródłaJacobs, Amy. "Covalent Inhibition of HIV Membrane Fusion". Biophysical Journal 96, nr 3 (luty 2009): 359a. http://dx.doi.org/10.1016/j.bpj.2008.12.1814.
Pełny tekst źródłaHuang, Huang, Christina A. Howard, Sergei Zari, Hyo Je Cho, Shirish Shukla, Hao Li, Juliano Ndoj i in. "Covalent inhibition of NSD1 histone methyltransferase". Nature Chemical Biology 16, nr 12 (31.08.2020): 1403–10. http://dx.doi.org/10.1038/s41589-020-0626-6.
Pełny tekst źródłaAmara, Neri, Roi Mashiach, Dotan Amar, Pnina Krief, Stéphane A. H. Spieser, Matthew J. Bottomley, Amir Aharoni i Michael M. Meijler. "Covalent Inhibition of Bacterial Quorum Sensing". Journal of the American Chemical Society 131, nr 30 (5.08.2009): 10610–19. http://dx.doi.org/10.1021/ja903292v.
Pełny tekst źródłaKentner, Taryn A., Leslie R. Berry i Anthony K. C. Chan. "Inhibition of Factor Xa in Prothrombinase Is Enhanced by Covalent Linkage of Antithrombin to Heparin." Blood 104, nr 11 (16.11.2004): 1051. http://dx.doi.org/10.1182/blood.v104.11.1051.1051.
Pełny tekst źródłaNAGUMO, Yoko, Hideaki KAKEYA, Mitsuru SHOJI, Yujiro HAYASHI, Naoshi DOHMAE i Hiroyuki OSADA. "Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity". Biochemical Journal 387, nr 3 (26.04.2005): 835–40. http://dx.doi.org/10.1042/bj20041355.
Pełny tekst źródłaJebaraj, Billy Michael Chelliah, Annika Müller, Rashmi Priyadharshini Dheenadayalan, Sascha Endres, Philipp M. Roessner, Felix Seyfried, Claudia Walliser i in. "Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia". Blood 139, nr 6 (10.02.2022): 859–75. http://dx.doi.org/10.1182/blood.2021011516.
Pełny tekst źródłaWágner, Gábor, Tamara A. M. Mocking, Albert J. Kooistra, Inna Slynko, Péter Ábrányi-Balogh, György M. Keserű, Maikel Wijtmans, Henry F. Vischer, Iwan J. P. de Esch i Rob Leurs. "Covalent Inhibition of the Histamine H3 Receptor". Molecules 24, nr 24 (11.12.2019): 4541. http://dx.doi.org/10.3390/molecules24244541.
Pełny tekst źródłaThøgersen, I. B., G. Salvesen, F. H. Brucato, S. V. Pizzo i J. J. Enghild. "Purification and characterization of an α-macroglobulin proteinase inhibitor from the mollusc Octopus vulgaris". Biochemical Journal 285, nr 2 (15.07.1992): 521–27. http://dx.doi.org/10.1042/bj2850521.
Pełny tekst źródłaShatan, Anastasiia B., Vitalii Patsula, Hana Macková, Andrii Mahun, Renáta Lehotská, Elena Piecková i Daniel Horák. "Silver-Sulfamethazine-Conjugated β-Cyclodextrin/Dextran-Coated Magnetic Nanoparticles for Pathogen Inhibition". Nanomaterials 14, nr 4 (17.02.2024): 371. http://dx.doi.org/10.3390/nano14040371.
Pełny tekst źródłaLee, Jesang, i Seung Bum Park. "Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets". Pharmaceuticals 15, nr 12 (27.11.2022): 1478. http://dx.doi.org/10.3390/ph15121478.
Pełny tekst źródłaWalderveen, Maria Christina Van, Leslie Roy Berry, Helen Mary Atkinson i Anthony Kam Chuen Chan. "Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va". Thrombosis and Haemostasis 103, nr 05 (2010): 910–19. http://dx.doi.org/10.1160/th09-07-0473.
Pełny tekst źródłaAllgardsson, Anders, Lotta Berg, Christine Akfur, Andreas Hörnberg, Franz Worek, Anna Linusson i Fredrik J. Ekström. "Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6". Proceedings of the National Academy of Sciences 113, nr 20 (2.05.2016): 5514–19. http://dx.doi.org/10.1073/pnas.1523362113.
Pełny tekst źródłaLee, Chang-Uk, i Tom N. Grossmann. "Reversible Covalent Inhibition of a Protein Target". Angewandte Chemie International Edition 51, nr 35 (13.07.2012): 8699–700. http://dx.doi.org/10.1002/anie.201203341.
Pełny tekst źródłaAhmed, Vanessa F., Nunzio Bottini i Amy M. Barrios. "Covalent Inhibition of the Lymphoid Tyrosine Phosphatase". ChemMedChem 9, nr 2 (8.01.2014): 296–99. http://dx.doi.org/10.1002/cmdc.201300404.
Pełny tekst źródłaStevic, Ivan, Howard H. W. Chan, Ankush Chander, Leslie R. Berry i Anthony K. C. Chan. "Inhibition of Platelet-Prothrombianse by a Covalent Antithrombin-Heparin Complex." Blood 120, nr 21 (16.11.2012): 2212. http://dx.doi.org/10.1182/blood.v120.21.2212.2212.
Pełny tekst źródłaZhou, Yuxin, Ji Tao, Dingshuainan Jin, Shiping Zhang, Yan He i Longlong Niu. "The Inhibition Effect and Mechnism of a Thiadiazole Derivative on Q235 Carbon Steel in 1 M HCl Solution". Applied Sciences 13, nr 4 (6.02.2023): 2103. http://dx.doi.org/10.3390/app13042103.
Pełny tekst źródłaBuneeva, O. A., L. N. Aksenova i A. E. Medvedev. "A Simple Approach for Pilot Analysis of Time-dependent Enzyme Inhibition: Discrimination Between Mechanism-based Inactivation and Tight Binding Inhibitor Behavior". Biomedical Chemistry: Research and Methods 3, nr 1 (2020): e00115. http://dx.doi.org/10.18097/bmcrm00115.
Pełny tekst źródłaWang, Qian, Guofeng Chen, Jian He, Jiameng Li, Muya Xiong, Haixia Su, Minjun Li, Hangchen Hu i Yechun Xu. "Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease". International Journal of Molecular Sciences 24, nr 10 (11.05.2023): 8633. http://dx.doi.org/10.3390/ijms24108633.
Pełny tekst źródłaAbdeldayem, Ayah, Yasir S. Raouf, Stefan N. Constantinescu, Richard Moriggl i Patrick T. Gunning. "Advances in covalent kinase inhibitors". Chemical Society Reviews 49, nr 9 (2020): 2617–87. http://dx.doi.org/10.1039/c9cs00720b.
Pełny tekst źródła